Total Funding
73
73
Total FundingSeries A raised
Growth Score
-3 pts
Heat Score
6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
9666
GC Therapeutics uses synthetic biology to program patient-derived stem cells into various cell types in an efficient and scalable manner.
- Parastoo Khoshakhlagh: Co-Founder and Chief Executive Officer
- Alex Ng: Co-Founder and Chief Innovation OfficerPast Role: GC Therapeutics, Co-Founder and Chief Scientific Officer
About the Company
GC Therapeutics uses synthetic biology to program patient-derived stem cells into various cell types in an efficient and scalable manner. They have verified cells for several applications by dictating cell fates in a single step. They've also created SuperCells™ by customizing cells for certain conditions. Professor George Church's lab at
Harvard Medical School is where GC Therapeutics' fundamental technology was developed, invented, and refined. They are a group of dedicated biologists and tissue engineers whose mission is to bring this ground-breaking method to patients.
